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Summary 29 
 Paroxysmal gluten-sensitive dyskinesia (PGSD; previously termed canine epileptoid 30 
cramping syndrome) is a condition of Border terriers in which the leading manifestation is 31 
neurological. We describe a case we believe to represent the first report of a Border terrier 32 
with a combination of neurological signs, atopy, positive serological results for anti-33 
transglutaminase 2 (TG2 IgA) and anti-gliadin (AGA IgG) antibodies, and signs suggestive of 34 
gastrointestinal disease with pathological changes in the gastrointestinal tract - seemingly 35 
responsive to a gluten-free diet. As such we suggest that gluten sensitivity in Border terriers 36 
may manifest as a multisystem disease in a similar manner to that seen in humans. 37 
 38 
Words 95 39 
  40 
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Introduction 41 
Gluten related disorders (GRD) include a spectrum of multisystem manifestations 42 
occurring as a consequence of an autoimmune reaction to gluten with or without signs of 43 
gastrointestinal disease (Sapone et al., 2012). Gluten is a protein composite of gliadin and 44 
glutenin, present along with starch in wheat. Coeliac disease (CD) or gluten sensitive 45 
enteropathy is a common cause of malabsorption in people and the most well recognised 46 
GRD (Catassi and Fasano, 2013). In genetically predisposed individuals, an immune reaction 47 
involving B cells, antibody production and intestinal mucosal T-lymphocytes, leads to 48 
intestinal inflammation (gluten sensitive enteropathy). An increasing number of patients are 49 
being recognised as suffering from gluten sensitivity, complaining of gastrointestinal and 50 
extra intestinal symptoms but without evidence of enteropathy. Non-coeliac gluten sensitivity 51 
(NCGS) is the term given for this phenomenon (Sapone et al., 2012). 52 
 53 
Gluten sensitivity in dogs has been largely unrecognized. A gluten sensitive 54 
enteropathy has been described in Irish Setters (Hall and Batt 1990; Garden et al., 2000) and 55 
more recently a paroxysmal gluten-sensitive dyskinesia (PGSD) has been reported in Border 56 
terriers (Lowrie et al., 2015). Paroxysmal gluten-sensitive dyskinesia (previously termed 57 
‘canine epileptoid cramping syndrome’) is characterised by circumscribed attacks of disturbed 58 
movement without loss of consciousness, superimposed on a background state in which such 59 
abnormality is absent. Episodes are seen in dogs as young as 6 weeks up to 7 years of age 60 
(Black et al., 2014). PGSD consists of episodes of difficulty walking, ranging from ataxia to a 61 
complete inability to stand, tremors, and dystonia of the limbs, head and neck. Episodes can 62 
last minutes or hours with dogs being normal in between. Up to 50% of dogs are reported to 63 
have associated gastrointestinal or dermatological signs (Black et al., 2014). 64 
 65 
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The current report describes the first report of a canine gluten sensitivity with 66 
presumed multi-system involvement. 67 
 68 
Case History 69 
A 2-year 6-month-old male neutered Border terrier was presented for evaluation of 70 
several strange post-prandial episodes, consisting of mild whole body tremors, licking the 71 
lips, staring into space, adopting a praying posture, mild dyskinesia of the limbs and 72 
becoming mildly ataxic with slow, purposeless pacing (see Video 1). These episodes would 73 
last several minutes after which he would return to normal. Occasional borborygmi, 74 
flatulence, haematochezia and faecal mucus were reported by the owner. Frequency and 75 
duration of the abnormal episodes increased progressively over a 6-month period with 76 
neurological signs increasing in severity. At presentation, the dog exhibited multiple 77 
consecutive episodes following eating, but the primary concern of the owner was the 78 
gastrointestinal signs. 79 
 80 
The referring veterinarian had performed a complete blood cell count (CBC) and 81 
serum chemistry panel, which were unremarkable. A canine specific pancreatic lipase 82 
immunoassay (Spec cPL) was negative. A bile acid stimulation test, TLI, folate and 83 
cobalamin were also within the respective reference intervals. No abnormalities were detected 84 
on urinalysis. A bacterial culture of urine showed no growth. Faecal microscopy and culture 85 
were unremarkable. Up to this point the dog had undergone a number of dietary trials using 86 
novel protein sources but with no clinical improvement. Despite varied diets with controlled 87 
exposure to many protein sources, all diets had contained gluten. Symptomatic therapy with 88 
ranitidine had failed to improve this clinical picture. 89 
 90 
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When initially examined at the referral hospital, the dog was alert with a body 91 
condition score of 4/9. Additional history revealed a life-long history of chewing the paws 92 
and frequent episodes of scratching of the left ear. Otoscopic examination revealed left sided 93 
otitis externa. The physical and neurological examination did not reveal abnormalities. 94 
Measurement of resting plasma ammonia concentration was within the reference interval. 95 
Thoracic radiographs and an abdominal ultrasound examination did not reveal abnormalities. 96 
Serum anti-transglutaminase 2a (TG2 IgA, 1.007; reference interval 0.129-0.285) and anti-97 
gliadinb (AGA IgG, 0.724; reference interval 0.092-0.162) antibodies were increased 98 
compared to previously reported controls (Lowrie et al., 2015). 99 
 100 
A gastroduodenoscopy revealed a small amount of fluid in the oesophagus but no 101 
signs of oesophagitis. There were no gross abnormalities in the stomach or duodenum. Lower 102 
gastrointestinal endoscopy revealed erythematous foci in the transverse colon and prominent 103 
follicles in the descending colon. The ileocecocolic valve appeared inflamed. Blind biopsies 104 
of the ileum were collected. Biopsies were also taken from the oesophagus, stomach, 105 
duodenum, ileum, caecum and colon. Histopathological review revealed the surface 106 
epithelium of the duodenum and ileum to be intact with villi of normal length on all 107 
specimens submitted. Histopathological grading was performed using standard criteria (Day 108 
et al., 2008). No gastric spiral microorganisms were observed. Gastric cells were mainly tall 109 
columnar, with mild increases of up to 10 intraepithelial lymphocytes per stretch of 50 110 
enterocytes. There were mild to moderate increases in numbers of lymphocytes and plasma 111 
cells in the superficial lamina propria in a few foci (30-60 per stretch of 100 enterocytes) and 112 
a mild increase of up to eight eosinophils clustered per 100 enterocytes (see figure 1). In the 113 
propria of the villi in the ileac samples there were mildly increased numbers of lymphocytes 114 
and plasma cells (up to 30% of surface length) at a x40 field (although the ileum is not 115 
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included in the WSAVA histological criteria). Eosinophils were mildly increased at up to 10 116 
per stretch of 100 enterocytes in the lamina propria and there were a few scattered 117 
neutrophils. The crypts of the colon were mildly hyperplastic in some areas, with up to 10 118 
lymphocytes and plasma cells between the crypts. Up to ten eosinophils were present per 100 119 
enterocytes, with some rare scattered neutrophils. The histopathological diagnosis was of a 120 
mild to moderate gastritis, enteritis and colitis with a lymphocytic, plasmocytic and 121 
eosinophilic population. 122 
 123 
Based on the history, physical examination, and test results, a diagnosis of a gluten 124 
sensitive enteropathy was suspected with dermatological and neurological manifestations. A 125 
gluten-free dietc was started with instructions to the owners to avoid all other sources of food. 126 
 127 
Over the next 14 days the owners reported no further abnormal episodes following 128 
eating, the signs suggestive of gastrointestinal disease abated and the pruritus completely 129 
resolved. Repeated serum titres of AGA (AGA IgG, 0.189; reference interval 0.092-0.162) 130 
and TG2 (TG2 IgA, 0.401; reference interval 0.129-0.285) antibodies 12 weeks following the 131 
institution of the gluten-free diet were significantly decreased, although both remained above 132 
the concentration of normal control dogs. 133 
 134 
Discussion 135 
 This is, to our knowledge, the first report of suspected combined intestinal and 136 
extraintestinal manifestations of gluten sensitivity in a Border terrier. Although gluten 137 
sensitivity resulting in multi-system manifestations is not proven, the evidence is compelling. 138 
Serological tests used to confirm the diagnosis of gluten sensitivity in people include AGA 139 
and TG2 antibodies (Hadjivassiliou 2003; Volta et al., 2012). In people, TG2 antibodies are 140 
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specific for enteropathy but are only found in a third of patients with neurological 141 
manifestations (Hadjivassiliou et al., 2010; Hadjivassiliou et al., 2014). In order to overcome 142 
these shortcomings, various transglutaminase isoenzymes have been studied. Antibodies to 143 
TG2, the autoantigen in CD, are seen with enteropathy. Antibodies to TG3 are associated with 144 
dermatitis herpetiformis (Sárdy et al., 2002) and antibodies to TG6 are found in the majority 145 
of patients with neurologic manifestations (Hadjivassiliou 2008; Hadjivassiliou et al., 2013). 146 
The latter two tests are not routinely available. 147 
 148 
 Accurate prevalence of neurological complications due to gluten sensitivity in people 149 
is not known. In patients with established CD, the reported prevalence of neurological 150 
complications ranges from 10-22.5% (Hadjivassiliou et al., 2014). Similarly, in patients with 151 
neurological manifestations, gastrointestinal symptoms are only detectable in 10% of the 152 
cases, but biopsy evidence of CD can be found in up to one-third (Hadjivassiliou et al., 2008). 153 
This is true in Border terriers with PGSD where despite a history of chronic diarrhoea and 154 
vomiting there were unremarkable histological abnormalities of the small intestine (Lowrie et 155 
al., 2015). 156 
 157 
In our case, the dog had an initial presentation of pruritus that had been present for 158 
approximately 18 months and preceded all other clinical signs. The dog later developed mild 159 
signs of ‘canine epileptoid cramping syndrome’ (Black et al., 2014) and presented to the 160 
referring veterinarian for evaluation of signs relating to a gastrointestinal complaint associated 161 
with feeding. When the dog was started on a gluten-free diet, it not only improved the 162 
gastrointestinal condition, but also the signs consistent with the neurological and 163 
dermatological disease. We cannot exclude that the neurological and dermatological signs 164 
may have been caused by malabsorption of a vitamin or essential nutrient. As the 165 
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inflammatory bowel disease improved, the micronutrient deficiency might have been 166 
corrected, improving the neurological signs. However, observations in people and dogs 167 
(Ghazal et al., 2012; Lowrie et al., 2015) contradict this hypothesis whereby a patient may 168 
present with neurological signs in the absence of an enteropathy and improve on a gluten-free 169 
diet. A more feasible explanation for the gastrointestinal, neurological and dermatological 170 
signs described is an immunological link between the three. The exact mechanism of this 171 
relationship between gluten sensitivity and the diverse manifestations is not well established 172 
at this time and requires further research to be undertaken. 173 
 174 
The presence of a lymphocytic-eosinophilic enteritis should be viewed with caution 175 
owing to the apparent discordance between clinical presentation and severity of inflammation 176 
and the frequent findings of enteritis in clinically silent dogs (Willard and Mansell, 2011). It 177 
is stated that the decision to biopsy should be taken only once therapeutic trials (e.g. dietary, 178 
antibiotic, anthelmintic, probiotic) have been performed (Washabau et al., 2010). Various 179 
food trials had been carefully performed on this dog before investigation was undertaken at 180 
the referral hospital. Furthermore, the presence of gastrointestinal inflammation with positive 181 
gluten serological test results and the occurrence of signs suggestive of gastrointestinal 182 
disease support the notion that gluten can result in an immune-mediated enteropathy, 183 
encephalopathy and dermatopathy. 184 
 185 
We accept that there are a number of limitations in this report. The therapeutic diet 186 
given to this dog was selected because it was gluten free. However, inevitably there will be 187 
many other differences between this diet and the foodstuffs previously administered. 188 
Therefore any improvement in clinical signs in response to change of diet cannot be attributed 189 
just to one component of the diet and hence a direct link to gluten sesnitvitiy is not proven 190 
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here although its association with a serological and clinical improvement is strongly 191 
supportive of a causal relationship. The serological tests performed in this dog only; indicate 192 
that an immune response has been mounted to exposure to gliadin and does not confirm that 193 
the clinical signs are due to gluten exposure. Furthermore, a reduction in AGA and TG2 194 
antibody concentrations following a change to a gluten-free diet would be expected due to 195 
decreased exposure and this change may not be of clinical significance. The only way to 196 
conclusively prove a clinical association with gluten would be to re-challenge the dog with 197 
gluten to document a recurrence of clinical signs. 198 
 199 
Conclusions 200 
This case report demonstrates the spectrum of clinical multisystem manifestations that 201 
may be associated with gluten sensitivity in Border terriers. Recognition of clinical signs 202 
suggestive of neurological, gastrointestinal and dermatological disease may aid in the 203 
identification of this condition and alert the clinician to the consideration of gluten serological 204 
testing. Strict adherence to a gluten-free diet allows a serological response in addition to 205 
complete amelioration of all associated clinical signs. 206 
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Videos 280 
 281 
Video 1 – A 2-year 6-month-old male neutered Border terrier exhibiting a post-prandial episode 282 
of whole body mild tremors, licking the lips, staring into space, adopting a preying posture, 283 
mild dyskinesia of the limbs and mild ataxia with slow, purposeless pacing. 284 
  285 
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Figures 286 
 287 
Figure 1 – Duodenal mucosa from the dog. There is evidence of alterations in mucosal immune 288 
cell populations, which are predominantly lymphocytes and plasma cells. Approximately 10 289 
intraepithelial lymphocytes per 100 enterocytes were identified.  Haematoxylin and eosin. Bar, 290 
200µm. 291 
 292 
